Williams D P, Parker K, Bacha P, Bishai W, Borowski M, Genbauffe F, Strom T B, Murphy J R
Evans Department of Clinical Research, University Hospital, Boston University Medical Center, MA 02118.
Protein Eng. 1987 Dec;1(6):493-8. doi: 10.1093/protein/1.6.493.
We have genetically replaced the diphtheria toxin receptor binding domain with a synthetic gene encoding interleukin-2 (IL-2) and a translational stop signal. The diphtheria toxin-related T-cell growth factor fusion gene encodes a 70 586-d polypeptide, pro-IL-2-toxin. The mature form of IL-2-toxin has a deduced mol. wt of 68,086 and is shown to be exported to the periplasmic compartment of Escherichia coli (pABI508), and contain immunologic determinants intrinsic to both its diphtheria toxin and IL-2 components. IL-2-toxin has been purified from periplasmic extracts of recombinant strains of E. coli (pABI508) by immunoaffinity chromatography using immobilized anti-IL-2. The purified chimeric toxin is shown to selectively inhibit protein synthesis in IL-2 receptor bearing targeted cells, whereas cell lines which do not express the IL-2 receptor are resistant to IL-2-toxin action.
我们已经用一个编码白细胞介素-2(IL-2)和一个翻译终止信号的合成基因,对白喉毒素受体结合结构域进行了基因替换。白喉毒素相关的T细胞生长因子融合基因编码一种70586个氨基酸的多肽,即前IL-2毒素。成熟形式的IL-2毒素推导分子量为68,086,并且已显示可输出到大肠杆菌(pABI508)的周质区室,并且含有其白喉毒素和IL-2成分固有的免疫决定簇。通过使用固定化抗IL-2的免疫亲和色谱法,已从大肠杆菌(pABI508)重组菌株的周质提取物中纯化出IL-2毒素。纯化的嵌合毒素显示可选择性抑制携带IL-2受体的靶细胞中的蛋白质合成,而不表达IL-2受体的细胞系对IL-2毒素作用具有抗性。